110 related articles for article (PubMed ID: 8892350)
1. Synthesis and secretion of active alpha 1-antichymotrypsin by murine primary astrocytes.
Kanemaru K; Meckelein B; Marshall DC; Sipe JD; Abraham CR
Neurobiol Aging; 1996; 17(5):767-71. PubMed ID: 8892350
[TBL] [Abstract][Full Text] [Related]
2. Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes.
Abraham CR; Kanemaru K; Mucke L
Brain Res; 1993 Sep; 621(2):222-32. PubMed ID: 8242336
[TBL] [Abstract][Full Text] [Related]
3. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
[TBL] [Abstract][Full Text] [Related]
4. Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin.
Rozemuller JM; Abbink JJ; Kamp AM; Stam FC; Hack CE; Eikelenboom P
Acta Neuropathol; 1991; 82(3):200-7. PubMed ID: 1927277
[TBL] [Abstract][Full Text] [Related]
5. Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)-antichymotrypsin in astrocytes: significance for Alzheimer's disease.
Nilsson LN; Das S; Potter H
Neurochem Int; 2001; 39(5-6):361-70. PubMed ID: 11578771
[TBL] [Abstract][Full Text] [Related]
6. Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA.
Pasternack JM; Abraham CR; Van Dyke BJ; Potter H; Younkin SG
Am J Pathol; 1989 Nov; 135(5):827-34. PubMed ID: 2817081
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1.
Das S; Potter H
Neuron; 1995 Feb; 14(2):447-56. PubMed ID: 7857652
[TBL] [Abstract][Full Text] [Related]
8. Developmental expression of alpha 1-antichymotrypsin in brain may be related to astrogliosis.
Koo EH; Abraham CR; Potter H; Cork LC; Price DL
Neurobiol Aging; 1991; 12(5):495-501. PubMed ID: 1837594
[TBL] [Abstract][Full Text] [Related]
9. The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease.
Abraham CR; Potter H
Ann Med; 1989; 21(2):77-81. PubMed ID: 2669847
[TBL] [Abstract][Full Text] [Related]
10. A calcium-stimulated serine protease from monkey brain degrades the beta-amyloid precursor protein.
Razzaboni BL; Papastoitsis G; Koo EH; Abraham CR
Brain Res; 1992 Sep; 589(2):207-16. PubMed ID: 1393590
[TBL] [Abstract][Full Text] [Related]
11. Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease.
Styren SD; Kamboh MI; DeKosky ST
J Comp Neurol; 1998 Jul; 396(4):511-20. PubMed ID: 9651008
[TBL] [Abstract][Full Text] [Related]
12. Allele-specific overexpression in astrocytes of an Alzheimer's disease associated alpha-1-antichymotrypsin promoter polymorphism.
Ritchie A; Morgan K; Kalsheker N
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):88-92. PubMed ID: 15530656
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human chymotrypsin-like proteases by alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin.
Hayem A; Marko D; Laine A; Davril M
Adv Exp Med Biol; 1988; 240():97-9. PubMed ID: 3266711
[No Abstract] [Full Text] [Related]
14. Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype.
Licastro F; Mallory M; Hansen LA; Masliah E
J Neuroimmunol; 1998 Aug; 88(1-2):105-10. PubMed ID: 9688331
[TBL] [Abstract][Full Text] [Related]
15. The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease.
Potter H
Prog Brain Res; 1992; 94():447-58. PubMed ID: 1287729
[No Abstract] [Full Text] [Related]
16. Alpha 1-antichymotrypsin is present together with the beta-protein in monkey brain amyloid deposits.
Abraham CR; Selkoe DJ; Potter H; Price DL; Cork LC
Neuroscience; 1989; 32(3):715-20. PubMed ID: 2689908
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-antichymotrypsin in brain aging and disease.
Abraham CR; Potter H
Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
[TBL] [Abstract][Full Text] [Related]
18. The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha.
Fiebich BL; Hofer TJ; Lieb K; Huell M; Butcher RD; Schumann G; Schulze-Osthoff K; Bauer J
Neuropharmacology; 1999 Sep; 38(9):1325-33. PubMed ID: 10471086
[TBL] [Abstract][Full Text] [Related]
19. In vivo catabolism of alpha 1-antichymotrypsin is mediated by the Serpin receptor which binds alpha 1-proteinase inhibitor, antithrombin III and heparin cofactor II.
Pizzo SV; Mast AE; Feldman SR; Salvesen G
Biochim Biophys Acta; 1988 Nov; 967(2):158-62. PubMed ID: 3263884
[TBL] [Abstract][Full Text] [Related]
20. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
